Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.
GLOBETECH PUBLISHING

Innovative Approach Developed for Sampling Gut Bacteria

By Labmedica International staff writers
Posted on 04 Jun 2014
Image: RNAlater, ribonucleic acid stabilization reagent (Photo courtesy of Qiagen).
Image: RNAlater, ribonucleic acid stabilization reagent (Photo courtesy of Qiagen).
A new protocol for collecting saliva and stool samples for genomic and transcriptomic analyses has been developed which eliminates the need for specialized personnel and facilities while keeping the sample intact.

The protocol provides critical insight into the genetic makeup of the microbiome of the digestive tract and the bacteria associated with celiac disease, oral cancer, periodontitis, and obesity and this technique will enable both longitudinal studies and large collection studies that are not limited by geography.

Scientists at the Forsyth Institute (Cambridge, MA, USA) with colleagues from other institutes conducted one of the first human microbiome studies in a well-phenotyped prospective cohort incorporating taxonomic, metagenomic, and metatranscriptomic profiling at multiple body sites using self-collected samples. Eight male subjects provided self-collected stool and saliva samples for shotgun metagenomic and metatranscriptomic sequencing.

To evaluate the effects of sample handling method on the assays, each stool sample was subdivided to produce three aliquots: a fresh frozen control sample, a sample fixed in ethanol, and a sample fixed in RNAlater (Qiagen; Valencia, CA, USA). From among the participants of a Health Professionals Follow-up Study, they selected 63 men who represented extremes of western versus prudent dietary intake and sent them kits for self-collection of saliva and stool at home. All DNA-based samples were then sequenced by Illumina HiSeq (San Diego, CA, USA), with each DNA sample run on a single sequencing lane, and each ribonucleic acid (RNA), (complementary DNA, cDNA) sample run on a pair of sequencing lanes.

The scientists found that within-subject microbial species, gene, and transcript abundances were highly concordant across sampling methods, with only a small fraction of transcripts less than 5%, displaying between-method variation. The team investigated relationships between the oral and gut microbial communities, identifying a subset of abundant oral microbes that routinely survive transit to the gut but have minimal transcriptional activity there. Systematic comparison of the gut metagenome and metatranscriptome revealed that a substantial fraction of 41% of microbial transcripts was not differentially regulated relative to their genomic abundances.

Jacques Izard, PhD, a coauthor of the study said, “We are excited about the opportunities this protocol presents for future large-scale studies. As the sensitivity of the sequencing technologies and the computing tools are improving, minute change can be detected. Our collaborative group demonstrated that we can analyze samples self-collected and shipped, in confidence for future biological marker discovery.” The study was published on May 19, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

Forsyth Institute 
Qiagen 
Illumina 



PURITAN MEDICAL
EUROIMMUN AG
Sekisui Diagnostics
comments powered by Disqus
Life Technologies

Channels

Pathology

view channel

New Approach Identifies Multiple Melanoma Drug Resistance Biomarkers

A recent paper described the use of liquid chromatography-multiple reaction monitoring mass spectrometry (LC-MRM) for assessing melanoma biomarkers in the blood in order to determine the effectiveness of chemotherapy. Modern chemotherapeutic techniques based on treatment with multiple anticancer drugs require the identification... Read more

Lab Technology

view channel
Image: Visualization from a numerical simulation of a cell flowing past the obstacle through the microfluidic device (Image courtesy of KTH – The Royal Institute of Technology).

Microfluidic Device Could Improve Biomarker Analyses

A new microfluidic device could offer a more reliable alternative for detecting biomarkers in patients facing such illnesses as cancer or malaria. The physical attributes of cells are important biomarkers... Read more

Industry News

view channel

IDT Acquires SURVEYOR Nuclease Product Line from Transgenomic

The SURVEYOR line is to be used by Integrated DNA Technologies (IDT; Coralville, IA, USA) primarily to support researchers performing mutation detection and potentially-clinical genome editing, and by Transgenomic, Inc. (Omaha, NE, USA) primarily to support diagnostic and other clinical applications. IDT, a world leader... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.